Topics

STAT Plus: Pharmalittle: White House claims Dem pricing bill will yield 100 fewer drugs; trade deal may remove some biologic protections

09:42 EST 4 Dec 2019 | STAT

Mexico is considering a U.S. proposal to remove protections for biologic medicines from a renegotiated trade deal, a plan that could help clear a hurdle to an agreement and deal…

Original Article: STAT Plus: Pharmalittle: White House claims Dem pricing bill will yield 100 fewer drugs; trade deal may remove some biologic protections

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Pharmalittle: White House claims Dem pricing bill will yield 100 fewer drugs; trade deal may remove some biologic protections"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...